enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Syndrome of inappropriate antidiuretic hormone secretion

    en.wikipedia.org/wiki/Syndrome_of_inappropriate...

    SIADH is less common than appropriate release of ADH. While it should be considered in a differential, other causes should be considered as well. [15] Cerebral salt wasting syndrome (CSWS) also presents with hyponatremia, there are signs of dehydration for which reason the management is diametrically opposed to SIADH. Importantly CSWS can be ...

  3. Tolvaptan - Wikipedia

    en.wikipedia.org/wiki/Tolvaptan

    Tolvaptan, sold under the brand name Samsca among others, is an aquaretic drug that functions as a selective, competitive vasopressin receptor 2 (V 2) antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).

  4. Cerebral salt-wasting syndrome - Wikipedia

    en.wikipedia.org/wiki/Cerebral_salt-wasting_syndrome

    The term "cerebral hyponatremia" was suggested in the work of Epstein, et al. 1961. Inappropriate release of endogenous vasopressin is probably responsible for hyponatremia in tuberculous meningitis. Inability to excrete water normally is also a feature of the salt wasting of certain hyponatremic patients with pulmonary tuberculosis.

  5. Conivaptan - Wikipedia

    en.wikipedia.org/wiki/Conivaptan

    Conivaptan hydrochloride was discovered by Yamanouchi Pharmaceuticals and marketed by Astellas. Yamanouchi Pharmaceuticals filed a new drug application to the FDA for conivaptan hydrochloride to treat hyponatremia on 2 February 2004. On 1 December, Yamanouchi received approval for investigational hyponatremia treatment using conivaptan ...

  6. Talk : Syndrome of inappropriate antidiuretic hormone secretion

    en.wikipedia.org/wiki/Talk:Syndrome_of...

    The result is hyponatremia. Please correct the hyponatremia to hypernatremia. —Preceding unsigned comment added by Yama fakhri (talk • contribs) 21:36, 21 December 2009 (UTC) SIADH causes HYPOnatremia not HYPERnatremia, since the nephrons don't allow the loss of as much water as they should.

  7. Zepbound Weight Loss Medication Approved by FDA to Treat ...

    www.aol.com/fda-approves-weight-loss-medication...

    The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.. The ...

  8. SIADH - Wikipedia

    en.wikipedia.org/?title=SIADH&redirect=no

    This page was last edited on 5 September 2012, at 20:45 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.

  9. Fix problems signing into your AOL account - AOL Help

    help.aol.com/articles/help-signing-in

    Use the Sign-in Helper to locate your username and regain access to your account by entering your recovery mobile number or alternate email address.; To manage and recover your account if you forget your password or username, make sure you have access to the recovery phone number or alternate email address you've added to your AOL account.